Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer
The Role of Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer
1 other identifier
interventional
30
1 country
1
Brief Summary
The investigators hypothesize that a personalized yoga program with mindful movement implemented during breast cancer therapy will benefit women in multiple ways. The investigators predict that women participating in the program will experience less weight gain and fatigue and will have an improved quality of life compared to women not participating in the program. The investigators predict that this will be associated with decreased markers of inflammation. The investigators will also evaluate whether there is improved pathologic response rate compared to historical controls. This study will provide pilot data for a larger randomized controlled trial assessing whether program can provide long-term improvement in quality of life, weight maintenance, and the serum and tumor changes correlating with a reduced risk of recurrence and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Jan 2018
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2017
CompletedFirst Posted
Study publicly available on registry
August 25, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2019
CompletedSeptember 3, 2019
August 1, 2019
1.5 years
August 23, 2017
August 29, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Feasibility of enrolling patients to larger randomized controlled trial using yoga and mindful movement as measured the number of eligible patients enrolled
-Feasibility is defined as the ability to enroll 60% of eligible patients
Completion of study enrollment (estimated to be 6 months)
Feasibility of conducting a larger randomized trial using yoga and mindful movement
-Feasibility is defined as the ability to have an 80% completion rate of the intervention
Completion of study enrollment (estimated to be 6 months)
Efficacy of yoga exercise as measured by weight change from baseline to completion
Completion of treatment (estimated to be 6 months)
Secondary Outcomes (4)
Effect of yoga exercise as measured by rate of pathologic response (partial and complete) (neoadjuvant subset only)
Completion of treatment (estimated to be 6 months)
Effect of yoga exercise as measured by inflammatory markers
Completion of treatment (estimated to be 6 months)
Effect of yoga exercise as measured by fatigue index
Completion of treatment (estimated to be 6 months)
Effect of yoga exercise as measured by quality of life
Completion of treatment (estimated to be 6 months)
Study Arms (2)
Arm 1: Yoga
EXPERIMENTAL* Prior to start of treatment, a yoga therapist will work with each patient to develop a personalized yoga protocol using Gentle Hatha and Restorative Yoga * Each protocol will consist of 5-10 minutes of centering poses to invite focus and relaxation, then 15-20 minutes of seated and standing active poses, ending with 5-10 minutes of guided relaxation. * The personalized practice will be given to each participant and she will be asked to practice beginning at the start of neoadjuvant treatment at least 3 times a week (but preferably daily) at home for at least 30 minutes each time. Participants will continue their personalized yoga practice during the entirety of treatment. Each participant will be asked to journal when and for how long she practices at home and make any comments as to how the practice might have made her feel * During participation, weekly follow-up calls will be made by a member of the study team to each participant randomized to the yoga arm.
Arm 2: No Yoga
ACTIVE COMPARATOR-Patients in this arm will not receive a personalized yoga plan
Interventions
The yoga practice, Gentle Hatha and Restorative Yoga, will be based on protocols that have been found to decease fatigue and weight gain by helping the participant gain insight in recognizing stress responses and ways to relax
* Baseline and end of treatment * To evaluate change in inflammatory markers (CRP, IL-6, and TNF)
* 7 statements that other people with breast cancer have said are important, the patient is to circle or mark one number per line to indicate the response as it applies in the last 7 days * Answers range from 0=not at all to 4=very much
-Weight will be taken at baseline, on day 1 of each cycle, and the end of treatment
-To assess physical activity, the RPAQ will be completed at baseline and at the end of treatment.
-To assess diet, the NHANES Food Questionnaire will be completed at baseline and at the end of treatment.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Related Publications (1)
Greaney SK, Amin N, Prudner BC, Compernolle M, Sandell LJ, Tebb SC, Weilbaecher KN, Abeln P, Luo J, Tao Y, Hirbe AC, Peterson LL. Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221137285. doi: 10.1177/15347354221137285.
PMID: 36412916DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsay L Peterson, M.D., MSCR
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2017
First Posted
August 25, 2017
Study Start
January 10, 2018
Primary Completion
June 26, 2019
Study Completion
June 26, 2019
Last Updated
September 3, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share